BeyondSpring Inc (BYSI) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
BeyondSpring Inc stock (BYSI) is currently trading at $1.62. BeyondSpring Inc PS ratio (Price-to-Sales) is 45.99. Analyst consensus price target for BYSI is $1.25. WallStSmart rates BYSI as Sell.
- BYSI PE ratio analysis and historical PE chart
- BYSI PS ratio (Price-to-Sales) history and trend
- BYSI intrinsic value — DCF, Graham Number, EPV models
- BYSI stock price prediction 2025 2026 2027 2028 2029 2030
- BYSI fair value vs current price
- BYSI insider transactions and insider buying
- Is BYSI undervalued or overvalued?
- BeyondSpring Inc financial analysis — revenue, earnings, cash flow
- BYSI Piotroski F-Score and Altman Z-Score
- BYSI analyst price target and Smart Rating
BeyondSpring Inc
📊 No data available
Try selecting a different time range
Smart Analysis
BeyondSpring Inc (BYSI) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
BeyondSpring Inc (BYSI) Key Strengths (0)
Supporting Valuation Data
BeyondSpring Inc (BYSI) Areas to Watch (6)
Company is destroying shareholder value
Very expensive at 46.0x annual revenue
Very expensive at 5.4x book value
Very low institutional interest at 14.35%
Micro-cap company with very limited liquidity and high volatility
Solid revenue growth at 14.30% per year
Supporting Valuation Data
BeyondSpring Inc (BYSI) Detailed Analysis Report
Overall Assessment
This company scores 15/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 0 register as strengths (avg 0/10) while 6 fall into concern territory (avg 2.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
Limited fundamental strengths were identified. The bull case requires improvement in core metrics.
The Bear Case
The primary concerns are Return on Equity, Price/Sales, Price/Book. Some valuation metrics including Price/Sales (45.99), Price/Book (5.38) suggest expensive pricing. Growth concerns include Revenue Growth at 14.30%, which may limit upside. Profitability pressure is visible in Return on Equity at -310.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -310.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 14.30% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Price/Sales are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
BYSI Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
BYSI's Price-to-Sales ratio of 45.99x trades at a deep discount to its historical average of 563.64x (52th percentile). The current valuation is 99% below its historical high of 6453.17x set in Aug 2021, and 158% above its historical low of 17.8x in Nov 2022. Over the past 12 months, the PS ratio has expanded from ~33.2x, reflecting growing market expectations outpacing revenue growth.
WallStSmart Analysis Synopsis
Data-driven financial summary for BeyondSpring Inc (BYSI) · HEALTHCARE › BIOTECHNOLOGY
The Big Picture
BeyondSpring Inc operates as a stable business with moderate growth and solid fundamentals. Revenue reached 2M with 14% growth year-over-year. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Spending 55% of revenue (1M) on R&D, reinforcing its commitment to innovation and future growth.
Free cash flow is -4M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor BIOTECHNOLOGY industry trends, competitive moves, and regulatory changes that could impact BeyondSpring Inc.
Bottom Line
BeyondSpring Inc offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Data sourced from SEC Form 4 filings
Last updated: 8:25:29 AM
About BeyondSpring Inc(BYSI)
NASDAQ
HEALTHCARE
BIOTECHNOLOGY
USA
BeyondSpring Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology cancer therapies. The company is headquartered in New York, New York.